Head to head

Action II vs MCL31 Dermablate (2026)

The biggest practical difference is cost of entry: Action II's new pricing is $50k–$80k, while MCL31 Dermablate's is $70k–$100k. Both are used for er:yag resurfacing, so choose on consumable cost per treatment, cleared indications and how many treatments you can realistically book each month.

Category group: Resurfacing & pigment (ablative, fractional, picosecond, vascular)

Device A

Device B

Price comparison

Price comparison: Lutronic Action II vs Asclepion MCL31 Dermablate
Attribute	Lutronic Action II	Asclepion MCL31 Dermablate
New price range	$50k–$80k	$70k–$100k
Used asking range	$20k–$35k	$25k–$45k
Payback calculator	View ROI calculator	View ROI calculator
Next step

New price range

Lutronic Action II: $50k–$80k
Asclepion MCL31 Dermablate: $70k–$100k

Used asking range

Lutronic Action II: $20k–$35k
Asclepion MCL31 Dermablate: $25k–$45k

Payback calculator

Lutronic Action II: View ROI calculator
Asclepion MCL31 Dermablate: View ROI calculator

Next step

Lutronic Action II

Asclepion MCL31 Dermablate

Consumable economics

Consumable economics: Lutronic Action II vs Asclepion MCL31 Dermablate
Attribute	Lutronic Action II	Asclepion MCL31 Dermablate
Consumable cost / lock-in	—	—
Service cost	Not published	Not published

Consumable cost / lock-in

Lutronic Action II: —
Asclepion MCL31 Dermablate: —

Service cost

Lutronic Action II: Not published
Asclepion MCL31 Dermablate: Not published

FDA clearance

FDA clearance: Lutronic Action II vs Asclepion MCL31 Dermablate
Attribute	Lutronic Action II	Asclepion MCL31 Dermablate
FDA status & indication	FDA ClearedK163196 “The ACTION II Laser System is indicated for: coagulation, vaporization, ablation or cutting of soft tissue (skin) in Dermatology, Plastic Surgery, Oral Surgery, ENT, Gynecology, General Surgery, Podiatry and Ophthalmology (skin around the eyes). The ACTION II Laser Module Fractional Handpiece is indicated for: use in soft tissue (skin, cutaneous tissue, subcutaneous tissue, striated and smooth tissue, muscle, cartilage meniscus, mucous membrane, lymph vessels and nodes; organs, and glands) such as, but not limited to: Dermatology and Plastic Surgery: skin resurfacing treatment of wrinkles; epidermal nevi; telangiectasia; spider veins; actinic chelitis; keloids; verrucae; skin tags; anal tags; keratoses; scar revision (including acne scars).”	FDA ClearedK150140 “The MCL 31 Dermablate laser system is intended for coagulation, vaporization, ablation or cutting of soft tissue (skin) in Dermatology, Plastic Surgery, Oral Surgery, ENT, Gynecology, General Surgery, Podiatry and Ophthalmology (skin around the eyes). Summary of Technical Characteristics Proposed Modified Device Un-Modified Predicate Device Un-Modified Predicate Manufacturer 510(k) MCL 31 Dermablate Asclepion Laser Technologies Dermablate Effect with Handpiece of larger spot size Asclepion Laser Technologies Dynamis Er:YAG Laser Fotona Intended Use (handpiece with larger spot size) Coagulation, vaporization, ablation or cutting of soft tissue (skin) in Dermatology, Plastic Surgery, Oral Surgery, ENT, Gynecology, General Surgery, Podiatry and Ophthalmology (skin around the eyes). Coagulation, vaporization, ablation or cutting of soft tissue (skin) in dermatology, plastic surgery, oral surgery and ophthalmology (skin around the eyes). Surgical incision/excision, vaporization and coagulation of soft tissue during any general surgery application where skin incision, tissue dissection, excision of lesions, complete or partial resection of internal organs, lesions, tissue ablation and vessel coagulation is necessary. Dermatology and Plastic Surgery, ENT Surgery, Oral/Maxillofacial Indications, Ophthalmology, Gynecology, General Surgery, Podiatry. Laser medium wavelength Er:YAG 2940 nm Er:YAG 2940 nm Er :YAG 2940 nm Principle of interaction with skin Ablation, Coagulation Ablation, Coagulation Ablation, Coagulation Energy, max. 2,5 J 1,5 J 3,0 J Power, max. 20 W 12 W 20 W Frequency, max.”

FDA status & indication

Lutronic Action II: FDA ClearedK163196
“The ACTION II Laser System is indicated for: coagulation, vaporization, ablation or cutting of soft tissue (skin) in Dermatology, Plastic Surgery, Oral Surgery, ENT, Gynecology, General Surgery, Podiatry and Ophthalmology (skin around the eyes). The ACTION II Laser Module Fractional Handpiece is indicated for: use in soft tissue (skin, cutaneous tissue, subcutaneous tissue, striated and smooth tissue, muscle, cartilage meniscus, mucous membrane, lymph vessels and nodes; organs, and glands) such as, but not limited to: Dermatology and Plastic Surgery: skin resurfacing treatment of wrinkles; epidermal nevi; telangiectasia; spider veins; actinic chelitis; keloids; verrucae; skin tags; anal tags; keratoses; scar revision (including acne scars).”
Asclepion MCL31 Dermablate: FDA ClearedK150140
“The MCL 31 Dermablate laser system is intended for coagulation, vaporization, ablation or cutting of soft tissue (skin) in Dermatology, Plastic Surgery, Oral Surgery, ENT, Gynecology, General Surgery, Podiatry and Ophthalmology (skin around the eyes). Summary of Technical Characteristics Proposed Modified Device Un-Modified Predicate Device Un-Modified Predicate Manufacturer 510(k) MCL 31 Dermablate Asclepion Laser Technologies Dermablate Effect with Handpiece of larger spot size Asclepion Laser Technologies Dynamis Er:YAG Laser Fotona Intended Use (handpiece with larger spot size) Coagulation, vaporization, ablation or cutting of soft tissue (skin) in Dermatology, Plastic Surgery, Oral Surgery, ENT, Gynecology, General Surgery, Podiatry and Ophthalmology (skin around the eyes). Coagulation, vaporization, ablation or cutting of soft tissue (skin) in dermatology, plastic surgery, oral surgery and ophthalmology (skin around the eyes). Surgical incision/excision, vaporization and coagulation of soft tissue during any general surgery application where skin incision, tissue dissection, excision of lesions, complete or partial resection of internal organs, lesions, tissue ablation and vessel coagulation is necessary. Dermatology and Plastic Surgery, ENT Surgery, Oral/Maxillofacial Indications, Ophthalmology, Gynecology, General Surgery, Podiatry. Laser medium wavelength Er:YAG 2940 nm Er:YAG 2940 nm Er :YAG 2940 nm Principle of interaction with skin Ablation, Coagulation Ablation, Coagulation Ablation, Coagulation Energy, max. 2,5 J 1,5 J 3,0 J Power, max. 20 W 12 W 20 W Frequency, max.”

Which chains run each

Which chains run each: Lutronic Action II vs Asclepion MCL31 Dermablate
Attribute	Lutronic Action II	Asclepion MCL31 Dermablate
Chain adoption	0 recorded pairings	0 recorded pairings
Chains using it	—	—
Approved reviews	0	0

Chain adoption

Lutronic Action II: 0 recorded pairings
Asclepion MCL31 Dermablate: 0 recorded pairings

Chains using it

Lutronic Action II: —
Asclepion MCL31 Dermablate: —

Approved reviews

Lutronic Action II: 0
Asclepion MCL31 Dermablate: 0

Specs and platform

Specs and platform: Lutronic Action II vs Asclepion MCL31 Dermablate
Attribute	Lutronic Action II	Asclepion MCL31 Dermablate
Manufacturer	Lutronic	Asclepion
Built by (OEM)	Lutronic Corporation	Asclepion Laser Technologies GmbH
Category	Er:YAG Resurfacing	Er:YAG Resurfacing
Technology	Er:YAG 2940nm fractional/full-field (Erbium)	Er:YAG 2940nm fractional/full-field (Erbium)
Launch year	2012	2013
Status	Current	Current
OEM platform	—	—

Manufacturer

Lutronic Action II: Lutronic
Asclepion MCL31 Dermablate: Asclepion

Built by (OEM)

Lutronic Action II: Lutronic Corporation
Asclepion MCL31 Dermablate: Asclepion Laser Technologies GmbH

Alternatives

Other devices in the same subcategory.

Fotona XS Dynamis

Er:YAG Resurfacing

New: —

Sciton Contour TRL (Joule/mJoule module)

Er:YAG Resurfacing

New: —

Aerolase Era Elite

Er:YAG Resurfacing

New: $60k–$90k

Sciton ProFractional-XC

Er:YAG Resurfacing

New: —

Get a free recommendation Browse by goal

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Prices are researched estimates, not quotes. Not medical, legal or regulatory advice.